News & Press Releases

Home/News

FinancialAug 4, 2026

Revenue grew 14% on strong demand for Dermavia and Cardelle; full-year outlook raised.

FinancialMay 12, 2026

Revenue of $4.3 billion; pipeline advanced with two Phase 3 starts.

FinancialFeb 3, 2026

Full-year revenue rose 11%; dividend increased for the ninth consecutive year.

FinancialNov 4, 2025

Oncology revenue up 19%; operating margin expanded 120 basis points.

FinancialAug 5, 2025

Revenue of $3.9 billion; full-year outlook reaffirmed.

FinancialMay 6, 2025

Growth led by Dermavia, Velorix and Cardelle.

FinancialFeb 4, 2025

Full-year revenue of $15.1 billion; eight new molecular entities entered the clinic.

FinancialOct 29, 2024

Revenue up 9%; R&D investment increased to 22% of sales.

FinancialFeb 6, 2024

Revenue reached $13.9 billion; dividend raised 6%.

Showing all 9 releases